Deficiencies in DNA mismatch repair (MMR) have been found in hereditary colon cancers (hereditary nonpolyposis colon cancer, HNPCC) as well as in sporadic cancers, illustrating the importance of MMR in maintaining genomic integrity. We have examined the interactions of specific mismatch repair proteins in human nuclear extracts. Western blot and co-immunoprecipitation studies indicate two complexes as follows: one consisting of hMSH2, hMSH6, hMLH1, and hPMS2 and the other consisting of hMSH2, hMSH6, hMLH1, and hPMS1. These interactions occur without the addition of ATP. Furthermore, the protein complexes specifically bind to mismatched DNA and not to a similar homoduplex oligonucleotide. The protein complex-DNA interactions occur primarily through hMSH6, although hMSH2 can also become cross-linked to the mismatched substrate when not participating in the MMR protein complex. In the presence of ATP the binding of hMSH6 to mismatched DNA is decreased. In addition, hMLH1, hPMS2, and hPMS1 no longer interact with each other or with the hMutS␣ complex (hMSH2 and hMSH6). However, the ability of hMLH1 to co-immunoprecipitate mismatched DNA increases in the presence of ATP. This interaction is dependent on the presence of the mismatch and does not appear to involve a direct binding of hMLH1 to the DNA.
The DNA mismatch repair system acts to recognize and repair mispaired nucleotides and plays an important role in maintaining genomic integrity (for reviews see Refs. [1] [2] [3] . The importance of this mutation avoidance system can be seen in HNPCC 1 kindreds, where germ-line mutations in the genes associated with mismatch repair lead to microsatellite instability, elevated mutation rates, and predisposition to cancer (4, 5) . Similar defects in MMR have also been found in spontaneous colon cancers and other solid tumors (6) . Although the precise functions of the human MMR proteins are just beginning to be understood, the human MMR genes are homologous to those in the relatively well characterized Escherichia coli MutHLS strand-specific mismatch repair pathway (for review see Ref. 7) . Indeed, the degree of conservation between such divergent species reflects the essential role of MMR. In bacteria, the MutS protein recognizes mismatches and initiates the repair process. Next, MutS interacts with MutL and translocates along the DNA strand, forming an ␣-loop structure (8) . This process requires ATP hydrolysis and MutL interaction, although the exact role MutL plays is unclear. Following MutH incision of the unmethylated strand, a segment of DNA is excised by Rec I, exonuclease I, or exonuclease VII, and the DNA is re-synthesized by the polymerase III holoenzyme.
In humans, the MMR pathway is more complex than that of E. coli. At least six genes have now been demonstrated to be involved in eukaryotic MMR. These include the MutS homologs hMSH2, hMSH6, and hMSH3 and the MutL homologs hMLH1, hPMS2, and hPMS1 (for reviews see Refs. 9 and 10). hMSH2 and hMSH6 have been shown to interact with each other in the hMutS␣ heterodimer that binds to heteroduplex DNA (11) (12) (13) . hMSH2 can also pair with hMSH3 to form the hMutS␤ heterodimer that preferentially binds to small insertion/deletion loops (14, 15) . Both hMSH2 and hMSH6 have intrinsic ATPase activity (16 -18) . In the presence of mismatched DNA the hMutS␣ heterodimer binds to ATP, resulting in its release from or translocation along oligonucleotide substrates (18 -20) . As with bacteria, the exact roles of the MutL homologs are still unclear in human cells. It has been shown that a heterodimer of hPMS2 and hMLH1 is capable of restoring mismatch repair activity in human cancer cells that are hMLH1-deficient (21) , suggesting the existence of a hMutL␣ heterodimer. In addition, a heterodimer of hPMS1 and hMLH1 (hMutL␤) has recently been reported (22) .
Based on the E. coli model, it is hypothesized that the MutS and MutL homologs interact in the MMR process. In yeast purified yMSH2, yMLH1, and yPMS1 (homologous to human PMS2) proteins have been demonstrated by gel-shift analysis to interact with heteroduplex DNA (23) . In humans the hPMS2 and hMSH2 proteins have been shown to co-immunoprecipitate with hMLH1 (24) . The role of ATP in these eukaryotic MutS/MutL homolog interactions is unclear. In yeast the MutS-MutL homologs were reported to interact in the presence and absence of additional ATP (23) , whereas in other studies using purified proteins ATP was necessary to observe the interaction (25) . In humans, the co-precipitation of hPMS2 and hMSH2 with hMLH1 was observed to occur only in the presence of ATP (24) . It has been suggested that the MutL homologs could act to modulate the ATPase activity of the hMutS␣ heterodimer or that they act as "molecular matchmakers," recruiting other proteins that function in steps of DNA mispair correction subsequent to mismatch recognition.
To determine the exact interactions within nuclear extracts between MMR proteins and oligonucleotide substrates before and after addition of ATP we performed immunoprecipitation and Western blotting assays together with UV cross-linking to homoduplex and heteroduplex oligonucleotide substrates. We find that hMSH2, hMSH6, hMLH1, and either hPMS2 or hPMS1 (but not both together) co-immunoprecipitate in the absence of added ATP, indicating the presence of MMR protein complexes consisting of at least four MMR proteins. The protein-protein interactions occur in the presence of both homoduplex and heteroduplex DNA; however, we find that the complex specifically binds only to the mismatched substrate. This binding occurs primarily through hMSH6, although we also observe hMSH2 cross-linked to heteroduplex DNA when not in the larger MMR protein complexes. Addition of ATP results in a marked decrease in the amount of binding of the complexes to the oligonucleotide. Furthermore, co-immunoprecipitation followed by Western blot analysis demonstrates that the proteinprotein interaction between hMSH2 and hMSH6 (hMutS␣) remains intact but that hMLH1, hPMS2, and hPMS1 no longer associate either with each other or with the hMutS␣ complex. Interestingly, after the addition of ATP, hMLH1 has an increased ability to co-immunoprecipitate heteroduplex DNA, although it does not become UV cross-linked to it. This suggests that hMLH1 participates in a second protein complex involved in mismatch repair that may be involved in subsequent steps in the repair process.
EXPERIMENTAL PROCEDURES
Nuclear Extracts, Antibodies, and Reagents-HeLa nuclear extracts were prepared essentially as described by Dignum et al. (26) with final resuspension in a buffer consisting of 20 mM HEPES (pH 7.9), 20% glycerol, 0.1 M KCl, 0.2 mM EDTA, 0.2 mM phenylmethylsulfonyl fluoride, and 0.5 mM dithiothreitol. Antibodies against hMSH2 (polyclonal) were purchased from Oncogene (Cambridge, MA). Antibodies against hMSH6 (polyclonal), hMLH1 (polyclonal), hPMS2 (polyclonal), and hPMS1 (polyclonal) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). All other reagents were purchased from Sigma unless otherwise noted.
Preparation of Oligonucleotides-A 32-mer oligonucleotide having the sequence of 5Ј-GGTGGGCGCCGGCGGTGTGGGCAAGAGTGCG-C-3Ј (Operon; Alameda, CA) was used for these assays with the bold G specifying the location of the mismatch. The oligonucleotide was 5Ј-endlabeled using [␥- 32 P]ATP (6,000 Ci/mmol) (NEN Life Science Products) and T4 polynucleotide kinase (Promega; Madison, WI) and purified using a Sephadex G-25 spin column. The 32 P-labeled oligonucleotide was annealed to a complementary oligonucleotide containing a C (homoduplex) or a T (heteroduplex) opposite the bold G, thereby producing double-stranded oligonucleotides with similar specific radioactivities. The annealing was performed at a 1:3 molar ratio of labeled to unlabeled oligonucleotide in a final volume of 100 l in 10 mM Tris-HCl (pH 8.0), 10 mM MgCl 2 . The solution was heated to 95°C for 5 min and then allowed to cool to room temperature over 2 h. We found no detectable labeled single-stranded oligonucleotides present when these substrates were examined by native polyacrylamide gel electrophoresis.
UV Cross-linking and Immunoprecipitation-Nuclear protein-DNA binding reactions were carried out in a buffer containing 4% glycerol, 1 mM MgCl 2 , 0.5 mM EDTA, 0.5 mM dithiothreitol, 50 mM NaCl, 10 mM Tris-HCl (pH 7.5), 0.05 g/ml poly(dI-dC)⅐poly(dI-dC), and 165 g of nuclear extract in a total volume of 200 l for 30 min at room temperature. A DNA mixture containing 1.05 pmol of 32 P-labeled doublestranded oligonucleotide (either heteroduplex or homoduplex) and 27 pmol of unlabeled double-stranded homoduplex competitor (ϳ1:25 molar ratio 32 P-labeled to unlabeled oligonucleotide) was added, and the mixtures were placed on ice for 40 min. All subsequent steps were performed at 0 -4°C. The samples were cross-linked by a 5-min exposure in an UV Stratalinker (Stratagene; La Jolla, CA) and then immunoprecipitated overnight with 3 g of the indicated antibody. After incubation for 3 h with protein G-Sepharose (Amersham Pharmacia Biotech), the immunoprecipitates were recovered by centrifugation (200 ϫ g, 1 min), washed 2 times with a buffer consisting of 10 mM Tris-HCl (pH 8.0), 150 mM NaCl, 0.1% Triton X-100, 0.025% NaN 3 , and 0.1% bovine serum albumin, washed 1 time with a buffer consisting of 10 mM Tris-HCl (pH 8.0), 150 mM NaCl, and 0.025% NaN 3 , and then washed 1 time with a buffer consisting of 50 mM Tris-HCl (pH 6.8). Samples were resuspended in an SDS sample buffer, heated for 5 min at 100°C, and loaded on a 7.5% SDS-polyacrylamide gel. Following electrophoresis at 10 mA for 2 h, gels were dried and exposed to Biomax film (Eastman Kodak Co.). Assays involving ATP were performed as above except that ATP at 0.1 mM was added prior to the UV crosslinking step.
Western Blotting-Nuclear protein was bound to the DNA substrates, UV cross-linked, immunoprecipitated, and electrophoresed as above. The resulting gel was then transferred onto a nitrocellulose membrane for Western blot analysis. Membranes were blotted with a primary antibody against either hMSH2, hMSH6, hMLH1, hPMS2, or hPMS1. Bound antibodies were detected by ECL detection using a biotin-conjugated secondary antibody and streptavidin-horseradish peroxidase as described by the manufacturer (Amersham Pharmacia Biotech). Between each probe the membrane was stripped by 30 min incubation at 55°C in 100 mM 2-mercaptoethanol, 2% SDS, and 62.5 mM Tris-HCl (pH 6.7).
RESULTS

hMSH6, hMSH2, hMLH1, and Either hPMS2 or hPMS1 Form a MMR Protein Complex That Interacts Specifically with
Mismatched DNA-To determine the exact nature of the interactions between the MMR proteins, immunoprecipitation experiments were performed followed by Western blotting. HeLa nuclear extracts, which are mismatch repair proficient (27) , were incubated with a mixture of 32 P-labeled DNA substrate (either homoduplex or heteroduplex), unlabeled homoduplex competitor to control for non-mismatch-specific interactions, and poly(dI-dC)⅐poly(dI-dC) (not recognized as a mismatch) to control for nonspecific DNA binding. Use of whole nuclear extracts instead of purified proteins allowed us to search for novel protein interactions. The sequence of the oligonucleotide substrate used was based on that of Ha-ras with the mismatch located at the middle nucleotide of codon 10. Mutations at this location have not been found in any human tumors (28, 29) , and we have previously demonstrated 96% correct repair of GT mismatches at codon 10 in mammalian cells (30) , lending further support to the mismatch repair proficiency of our system.
Nuclear extracts were incubated with the DNA, the bound proteins were UV cross-linked to the oligonucleotides, and immunoprecipitation was performed followed by Western blotting. In Fig. 1 , antibody against hMSH6 was used for immunoprecipitation, and the resulting membrane was sequentially probed for hMSH6, hMSH2, hMLH1, hPMS2, and hPMS1, with stripping of bound antibody between each probe. As shown in lanes 1 and 2 of Fig. 1B , hMSH6 is capable of coimmunoprecipitating hMSH2, hMLH1, hPMS2, and hPMS1, indicating the existence of an MMR complex(es) consisting of at least these proteins. These protein-protein interactions occur in the absence of additional ATP and occur to an approximately equal extent in the presence of homoduplex or heteroduplex DNA. The protein-protein interactions within nuclear extracts can also be observed when the 32-mer oligonucleotides, both mismatch-containing and homoduplex, were omitted from the reaction (results not shown). As poly(dI-dC)⅐poly(dI-dC) was included in all reactions, we cannot conclusively state whether the complexes are pre-formed in the absence of any DNA; however, this is not a relevant in vivo condition for nuclear proteins.
In these same experiments, autoradiography was performed on parallel lanes to determine which of the proteins identified above were also capable of becoming UV cross-linked to the 32 P-labeled DNA. As seen in Fig. 1A four bands are observed that bind specifically to heteroduplex DNA (lane 2) and not to the similar homoduplex DNA (lane 1). By comparing the bands seen in Fig. 1A to those identified in the Western blots in Fig.  1B , it can be seen that the highest molecular weight band runs to approximately the same position on the gel as hMSH6. We believe this to be hMSH6 bound to the mismatched DNA because 1) the size of this band correlates with the predicted molecular mass of 160 kDa for hMSH6, 2) binding to the mismatched DNA is disrupted upon addition of ATP (see Fig.  5 ), and 3) a number of previous studies have indicated the mismatch-specific DNA binding activity of hMSH6 (13, 17) . We therefore conclude that the predominant mismatch-specific DNA binding activity that we observe within nuclear extracts in these studies is hMSH6. This binding to the DNA occurs only with the mismatched oligonucleotide and is not seen when the 32 P-labeled homoduplex substrate is used. We also observe mismatch-specific DNA-binding proteins that run to positions of approximately 115 (A), 95 (B), and 50 kDa (C) (indicated with arrows). These proteins may be components of the complexes involving hMSH2, hMSH6, hMLH1, and hPMS2/hPMS1. Alternatively, as HeLa nuclear extracts are mismatch repairproficient, these bands may represent proteins that become bound to mismatched DNA in subsequent steps in the repair process. The 115-kDa (A as marked by arrows) activity correlates with the observed positions of both hPMS2 and hPMS1. Further studies are necessary to determine if this band represents a previously undetected DNA binding activity of either the hPMS2 or hPMS1 protein.
To confirm that the MMR proteins exist as a protein complex within HeLa nuclear extracts, the above experiments were repeated using antibody against hMLH1 for the immunoprecipitation. Western blotting was then performed with the membrane probed with antibodies against hMSH6, hMSH2, hMLH1, hPMS2, and hPMS1. As seen in lanes 1 and 2 of Fig.  2 these experiments confirm the interaction between hMLH1 and hMSH2, hMSH6, hPMS2, and hPMS1 in the absence of added ATP. hMLH1 was able to co-immunoprecipitate each of the other proteins in the presence of both homoduplex and heteroduplex DNA in the absence of ATP. Similar co-immunoprecipitation of all the MMR proteins was observed when antibody against hMSH2 was used (results not shown). Interestingly, when antibody against hPMS2 is used for immunoprecipitation, hPMS1 does not co-immunoprecipitate (see Fig. 3 ). As well, antibody against hPMS1 does not co-immunoprecipitate hPMS2. As we observe co-precipitation of both hPMS2 and hPMS1 when antibodies against hMSH6 (Fig. 1), hMLH1 (Fig. 2) or hMSH2 (results not shown) are used for the initial immunoprecipitation, we conclude that either hPMS2 or hPMS1 exists in the MMR complex but not both together.
In Fig. 4 nuclear extracts were incubated with 32 P-labeled heteroduplex or homoduplex oligonucleotides; the proteins were UV cross-linked to the DNA, and then antibodies against four of the MMR proteins were used for separate immunoprecipitations. The proteins that became UV cross-linked to the labeled oligonucleotides were observed by autoradiography of the resulting gel. The same four proteins (hMSH6, approximately 115 (A), 95 (B), and 50 kDa (C)) became bound to the mismatched DNA and not to the homoduplex DNA when hMSH6, hMSH2, hMLH1, hPMS2, or hPMS1 were used for immunoprecipitation. The predominant mismatch-specific DNA binding activity is that of hMSH6 as identified in Fig. 1 , regardless of the antibody used for immunoprecipitation. The degree of binding by hMSH6 is greater when antibody against hMSH6 is used in a direct immunoprecipitation than when HeLa nuclear extracts were incubated with heteroduplex DNA in the absence of ATP, and immunoprecipitation was performed using antibody against hPMS1 (IP ab in lanes 1 and 4) or hPMS2 (IP ab in lanes  2 and 3) . After SDS-polyacrylamide electrophoresis and transfer to nitrocellulose, Western blotting was performed with the indicated antibody probes (Western antibody (ab)). Chemiluminescence was used for detection. 1 and 2) or presence (lanes 3) of 0.1 mM ATP. After hMSH6 immunoprecipitation and SDS-polyacrylamide electrophoresis, parallel lanes from the same gel as in A were transferred to a nitrocellulose membrane. Western blotting was performed with the indicated antibody probes (Western antibody (ab)). Chemiluminescence was used for detection with sequential stripping of the membrane between probes. The large dark band at the bottom of all gels results from detection of immunoglobulins used in immunoprecipitation.
hMSH6 is co-immunoprecipitated using antibodies against hMSH2, hMLH1, hPMS2, or hPMS1. This is the expected result because during the co-immunoprecipitations the proteinprotein interactions can be disrupted and thus further confirms that this band represents hMSH6. Alternatively, it is possible that the intensity of this band results from hMSH6 homomultimers bound to the oligonucleotides as well as binding by the larger mismatch repair complexes. However, we consider this to be unlikely as studies using purified hMSH6 have shown it to be incapable of binding to DNA when not interacting with hMSH2 in the hMutS␣ heterodimer (13) . The amount of hMSH6 UV cross-linked to the heteroduplex when antibody against hMSH2 is used is greater than that seen when antibody against hPMS1, hPMS2, or hMLH1 is used. This could be because the hMutS␣ complex alone binds to the mismatched DNA, in addition to the larger MMR complexes, or could reflect the strength of the protein-protein interaction between hMSH2 and hMSH6. When antibody against hMSH2 is used to immunoprecipitate, a unique band is observed of approximately 105 kDa. This corresponds to the known molecular mass of hMSH2 (102 kDa) and runs to approximately the same position as hMSH2 as indicated on the Western blots in Fig. 1B and Fig. 2 . Other investigators have demonstrated purified hMSH2 to be capable of specifically binding to mismatched DNA (31). As we cannot co-immunoprecipitate bound hMSH2 with antibodies against any of the other MMR proteins, it appears that hMSH2 in HeLa nuclear extracts does specifically bind to mismatched DNA but only when not associated with hMSH6 or the larger MMR complexes.
Protein Interactions after Addition of ATP-Nuclear extracts were incubated with 32 P-labeled heteroduplex or homoduplex oligonucleotides, and the proteins were UV cross-linked to the DNA as above, except that 0.1 mM ATP was added after incubation of the nuclear extract with the 32 P-labeled DNA but prior to UV cross-linking. In Fig. 5 , antibodies against hMSH6 and hMLH1 were used to immunoprecipitate proteins UV cross-linked to 32 P-labeled heteroduplex DNA with and without addition of ATP. The amount of hMSH6 that is bound to the mismatched substrate clearly decreases upon addition of ATP, regardless of the MMR antibody used for immunoprecipitation. This correlates with previous studies that have shown hMutS␣ to disassociate from oligonucleotide substrates upon binding of ATP (13, 16, 18, 19) . As well, when antibody against hMSH6 is used for immunoprecipitation after the addition of ATP, the amount of binding to the mismatched DNA by the other three proteins (approximately 115 (A), 95 (B), and 50 kDa (C)) also decreases. Binding by hMSH6 does not completely disappear when antibody against hMSH6 is used for immunoprecipitation in these experiments using 0.1 mM ATP. ATP concentrations of 10 mM do, however, completely obliterate hMSH6 binding (results not shown).
Interestingly, we detect a novel interaction between hMLH1 and the heteroduplex DNA when ATP is added to the nuclear extract-DNA incubation. As seen by comparing Fig. 5 , lanes 5 and 6, when ATP is added to an hMLH1 immunoprecipitation, the amount of mismatched oligonucleotide that co-precipitates increases, as evidenced by the increased amount of unbound co-immunoprecipitated oligonucleotide. This occurs specifically with the heteroduplex and not the homoduplex oligonucleotide. This phenomenon does not occur when antibody against any of the other MMR proteins is used. hMLH1 itself (70 kDa) does not become directly UV cross-linked to the DNA as a band at the expected site is not observed. However, the amount of labeled DNA bound to the proteins that run to approximately 95 (B) and 50 kDa (C) does increase. hMLH1, therefore, participates in an interaction with the heteroduplex DNA after addition of ATP. This interaction may include the B and C proteins but does not appear to involve a direct interaction FIG. 5 . Autoradiogram of immunoprecipitates after UV crosslinking in the absence or presence of ATP. The 32 P-labeled oligonucleotides containing GC (homoduplex) or GT (heteroduplex) were incubated with HeLa nuclear extracts. 0.1 mM ATP was added to samples in lanes 2, 4, and 6, and bound proteins were UV cross-linked to the DNA. Immunoprecipitation was then performed using antibodies against the indicated proteins (IP ab). After SDS-polyacrylamide electrophoresis, the resulting gels were dried and exposed to film. Arrows indicate hMSH6 and hMSH2 bound to 32 P-labeled oligonucleotides and free oligonucleotides that have co-immunoprecipitated.
FIG. 4. UV cross-linking of nuclear proteins to
32 P-labeled DNA and immunoprecipitation of the protein-DNA complexes with antibodies against MMR proteins. The 32 P-labeled 32-mer oligonucleotide duplex containing GC (homoduplex) or GT (heteroduplex) was incubated with HeLa nuclear extracts, and bound proteins were UV crosslinked to the DNA. Immunoprecipitation was performed with the indicated antibodies (IP ab) and the immunoprecipitates were electrophoresed on an SDSpolyacrylamide gel. The figure is an autoradiogram of the resulting gel. between hMLH1 and the mismatched oligonucleotide.
To compare the protein-protein interactions in the MMR complexes after addition of ATP, we also performed immunoprecipitation followed by Western blot analysis. As seen in each lane 3 of Fig. 1B , when antibody against hMSH6 is used to immunoprecipitate in the presence of ATP, hPMS2, hPMS1, and hMLH1 no longer co-precipitate. The only protein-protein interaction that remains after addition of ATP is that between hMSH2 and hMSH6. Each lane 3 of Fig. 2 demonstrates that hMLH1 no longer co-precipitates any of the MMR proteins after addition of ATP. Similar results were observed when antibodies against hPMS2, hPMS1, and hMSH2 were used for immunoprecipitation with all interactions disrupted after addition of ATP except that between hMSH2 and hMSH6 (results not shown). The lack of binding seen after addition of ATP in Figs. 1 and 2 also confirms that the observed co-immunoprecipitations are the result of specific MMR protein-protein interactions as these are known to be modulated by ATP.
DISCUSSION
To determine MMR protein-protein and protein-DNA interactions, we performed UV-cross-linking, immunoprecipitation, and Western blotting using HeLa nuclear extracts. In these studies we have identified protein interactions between the human MutS homologs hMSH2 and hMSH6 and the human MutL homologs hMLH1, hPMS1, and hPMS2. We observe these interactions to occur in the absence of ATP; thus ATP binding or hydrolysis is not a prerequisite for complex formation in HeLa nuclear extracts in these experiments. Although we observe both hPMS2 and hPMS1 in the complex, they do not co-precipitate each other. Thus the MMR complex involves either hPMS2 or hPMS1 but not both together. This is in agreement with a recent publication that describes the hMutL␤ complex of hMLH1 and hPMS1 as distinct from the hMutL␣ complex of hMLH1 and hPMS2 (22) . Our results indicate that either hMutL␣ or hMutL␤ is capable of interacting with hMutS␣ and binding to mismatched DNA. If these complexes are at least partially functionally redundant, this would explain the rarity of HNPCC kindreds with mutations in hPMS2 or hPMS1 (33) . We theorize that these different complexes have distinct, as yet unknown functions in the repair process.
The protein-protein interactions in nuclear extracts occur in the presence of both homoduplex and heteroduplex DNA. However, the protein complex binds specifically only to heteroduplex substrates. As previously reported (17), hMSH6 appears to be the predominant DNA-binding protein in this complex, although we also observe binding by proteins that run to approximately 115 (A), 95 (B), and 50 kDa (C). Interestingly, the position of the 115-kDa (A) mismatch binding activity is similar to that of hPMS2 and hPMS1 as identified by Western blotting. Current studies are in progress to determine if either hPMS2 or hPMS1 has an as yet unidentified DNA binding activity that allows it to become UV cross-linked to the heteroduplex DNA when in the MMR protein complex, or perhaps to function in subsequent steps in the repair process. However, we do not see a stronger 115-kDa (A) band when either hPMS2 or hPMS1 is used for direct precipitation as compared with the co-immunoprecipitations. If the 115-kDa (A) band is either hPMS2 or hPMS1, a stronger band would be expected when using antibody directed specifically against the protein, as during coimmunoprecipitation the non-covalent protein-protein interactions are easily disrupted during the immunoprecipitation procedure. This suggests that the 115-kDa (A) band may represent a distinct protein. Interestingly, the position of the B band correlates with the reported 94-kDa molecular mass of human exonuclease 1 (34) . This 5Ј 3 3Ј-exonuclease has previously been shown to interact physically with hMSH2 in human nuclear extracts (34) , and genetic studies in yeast have shown the yeast homolog to function in the same epistatic pathway as hMSH2 (35, 36) . The size of the C band could correlate with one or more of the RPC II, III, IV, and V subunits (37, 36, 40 , and 38 kDa, respectively), which are suspected to play a role in MMR through loading of proliferating cell nuclear antigen onto DNA (2) . It is also very probable that there are more proteins yet to be identified as necessary for mismatch repair in humans, such as a DNA helicase and a 3Ј 3 5Ј-exonuclease (2) . The identification of the three unknown mismatch binding proteins in our studies is therefore of interest.
We also observe hMSH2 to become UV cross-linked to the heteroduplex DNA but only when antibody against hMSH2 is used for direct immunoprecipitation (Fig. 4) . As this mismatchspecific DNA binding activity of hMSH2 does not co-immunoprecipitate with hMSH6, hMLH1, hPMS2, or hPMS1, we conclude that hMSH2 is able to bind to mismatched DNA but only when it is not participating in the larger MMR complexes identified here. One possibility could be that the hMSH2-protein interaction occurs when hMSH2 is bound to hMSH3 in the hMutS␤ heterodimer. Alternatively, as studies with purified hMSH2 have shown it to bind to mismatched oligonucleotides as a homomultimer (31), the band we observe could be due to an interaction between hMSH2 homomultimers and the mismatched substrate in nuclear extracts. Further studies are necessary to identify the proteins involved in this interaction and their possible function.
After addition of ATP to the mixtures we observed that the protein-protein interaction between hMLH1 and hPMS1 or hPMS2 is disrupted as well as the interaction between these proteins and the hMutS␣ heterodimer. The only protein-protein interaction that we continue to observe after addition of ATP is that between hMSH2 and hMSH6 (hMutS␣). This is in conflict with yeast studies that have reported that the MSH2, MSH6, and PMS1 complex either remains intact upon addition of ATP (23) or that the protein interactions increase in the presence of ATP (25) . We believe the most probable explanation for this apparent discrepancy is that the previous studies used purified proteins, whereas our experiments were performed using whole nuclear extracts. In the presence of ATP, the MMR-proficient HeLa nuclear extracts can proceed with the repair process resulting in the eventual disruption of the protein-protein interactions. The excess of ATP then prevents formation of the protein complex. Although the reactions were maintained at 0 -4°C throughout, the immunoprecipitations were performed overnight, allowing time for the mismatch repair processes to occur, even at these sub-optimal temperatures. Alternatively, it has been shown in E. coli that the heteroduplex substrate is necessary for MutS and MutL complex formation (37) . In our experiments the size of the oligonucleotide substrate used (32-mer) could affect the ability of the MutS and MutL homologs to form a complex with each other and with the DNA after the addition of ATP. Addition of ATP also decreases the amount of hMSH6 that becomes UV crosslinked to the DNA. Numerous studies involving purified hMSH2 and hMSH6 have confirmed that the purified hMutS␣ heterodimer disassociates from mismatch containing oligonucleotides upon binding of ATP (13, 16, 18, 19) .
In Fig. 5 we observe a novel interaction between hMLH1 and the mismatched DNA after the addition of ATP, with hMLH1 capable of co-immunoprecipitating the labeled heteroduplex and not homoduplex DNA. This suggests that hMLH1 participates in a complex that interacts specifically with mismatched DNA after addition of ATP. This complex does not appear to involve hMSH6. hMLH1 does not interact directly with the DNA as it does not become UV cross-linked to the oligonucleo-tide. Instead, hMLH1 may participate in a novel protein complex in which other proteins bind to the mismatched oligonucleotide. Other investigators (21) have failed to observe direct interactions between mismatch-containing DNA and the purified hMutL␣ heterodimer. This is understandable if the complex involves additional nuclear proteins that directly interact with the heteroduplex DNA and that have not as yet been identified. We do continue to observe mismatch-specific binding by the proteins that run to approximately 95 (B) and 50 kDa (C), suggesting that they participate in the novel hMLH1 containing complex.
Our findings suggest that hMLH1 plays a role in steps in the repair process subsequent to mismatch recognition. Although little is known in regard to the exact biochemical role of hMLH1 in humans, a number of studies in E. coli have shed some light on the subject. One suggested role for MutL is to facilitate the interactions between MutS and the proteins necessary for subsequent steps in the repair process such as MutH and DNA helicase II (7, 38 -41) . The ability of hMLH1 to participate in the initial complexes involving hMutS␣ as well as in the novel complex after addition of ATP suggests that it may have an analogous role in human mismatch repair. As well, recent studies have suggested that MutL acts as a molecular chaperone. This hypothesis arises from the observed homology of MutL to the molecular chaperone molecule Hsp90 (42) and recent x-ray crystallography studies that have shown it to similarly bind ATP and have a weak ATPase activity (32, 43) . Indeed, upon ATP hydrolysis the E. coli MutL protein was observed to undergo conformational changes that are likely to modulate the interactions between MutL and the other components of the repair machinery. In hMLH1, conformational changes upon ATP hydrolysis could result in the different protein-protein and protein-DNA interactions that we observe after addition of ATP to the reaction.
Genetic analysis of HNPCC kindreds has demonstrated the importance of the hMLH1 gene product in mismatch repair (33) with approximately 61% of HNPCC kindreds reported as of May, 1999, carrying mutations in the hMLH1 gene. The central role of hMLH1 in both the hMutL␣ and hMutL␤ heterodimers (with hPMS2 and hPMS1, respectively) (21, 22) and in both the MMR complexes described here helps to explain the genetic data. As well, the novel interaction we observe between hMLH1 and heteroduplex DNA suggests that hMLH1 may have a further unique role in steps in MMR subsequent to mismatch recognition.
Our results suggest a model for human MMR where the hMutS␣ heterodimer, in a complex with either hMutL␣ or hMutL␤, recognizes and binds to mispairs. The formation of these protein-protein complexes occurs in nuclear extracts in the absence of additional ATP. The complex can then stably bind to mismatched DNA, again in the absence of ATP. This protein-DNA complex contains either hPMS2 (hMutL␣) or hPMS1 (hMutL␤), suggesting possible distinct functions for each. In the presence of ATP, conformational changes occur resulting in the eventual release of the protein complex from the heteroduplex oligonucleotides and the dissociation of hMLH1 from hMutS␣ and hPMS2 or hPMS1. hMLH1 is then capable of further interaction with the mismatched DNA in a novel manner, presumably playing a role in subsequent steps in the repair process.
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